what does alembic pharmaceuticals do

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished drug formulations, with a focus on generics and compliance through its R&D and manufacturing facilities.

what products does alembic pharmaceuticals make

The company produces high-quality generic medicines, APIs through fermentation and chemistry-based methods, and operates as a trusted supplier of affordable pharmaceuticals across India and globally.

what sector is alembic pharmaceuticals in

Alembic Pharmaceuticals is part of the pharmaceutical sector, specifically involved in the research, development, manufacturing, and marketing of APIs and formulations.

when was alembic pharmaceuticals founded

Founded in 1932, Alembic Pharmaceuticals has a long-standing history in the Indian pharmaceutical industry, evolving from a small firm to a multinational company with a strong presence in Gujarat.

who owns alembic pharmaceuticals

Alembic Pharmaceuticals is a publicly listed company on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE), owned by its shareholders, with significant operations and market presence in India and beyond.

APLLTD

NSEBSE

Alembic Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE901L01018· Scrip: 533573

EN हिन्दी ગુજરાતી मराठी

₹७८३.९५

▼ 1.55 (-0.20%)

7/5/2026, 11:08:16 am

NSE

₹७८३.९५

▼ १.५५

-०.२०%

BSE

₹७८५.६५

▲ १६.९५

+०.००%

२४४ व्यापार दिन · 1Y कालावधी

आज 

उघडणे७९५.००

उच्चांक७९५.००

नीचांक७८१.२०

मागील बंद७८५.५०

व्हॉल्यूम२२,६९८

मूल्य₹१.८Cr

L: 781.20H: 795.00

52 आठवडे

नीचांक₹६३५.८०

उच्चांक₹१,१०७.९०

३१% 52 आठवड्यांच्या श्रेणीत

माहिती

दर्शनी मूल्य₹२

सूचीबद्ध2011-09-20

ISININE901L01018

SeriesA

BSE स्क्रिप533573

मुख्य निर्देशक

1D

+1.90%

1W

+3.23%

1M

+15.79%

3M

+2.54%

6M

-14.93%

मूल्यांकन

P/E (TTM)२५.५२

P/E (Qtr Ann.)२७.९६

P/Sales२.०७

बाजार भांडवल₹13277 Cr

वाढ (तिमाही)

महसूल+2.72%

PAT-10.09%

EPS-10.01%

नफाक्षमता

EBITDA मार्जिन१४.६%

निव्वळ मार्जिन८.१%

TTM EBITDA M.१५.२%

TTM निव्वळ M.९.४%

लाभांश

परतावा१.४०%

अलीकडील DPS₹११

देय प्रमाण१५६.९%

वाढ+0.00%

TTM महसूल

₹6419 Cr

TTM EBITDA

₹976 Cr

TTM PAT

₹604 Cr

TTM EPS

₹३०.७२

प्रति शेअर महसूल

₹३२६.६

तिमाही वित्तीय

महसूल

EBITDA

PAT

EPS

तिमाही	महसूल	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	1693 Cr	1525 Cr	247 Cr	177 Cr	138 Cr	₹7.01
2024-09-30	1648 Cr	1498 Cr	250 Cr	180 Cr	153 Cr	₹7.79
2024-06-30	1562 Cr	1407 Cr	226 Cr	157 Cr	135 Cr	₹6.85
2024-03-31	1517 Cr	1337 Cr	253 Cr	183 Cr	178 Cr	₹9.07
2023-12-31	1631 Cr	1449 Cr	254 Cr	185 Cr	180 Cr	₹9.18
2023-09-30	1595 Cr	1470 Cr	203 Cr	135 Cr	137 Cr	₹6.95
2023-03-31	1406 Cr	1283 Cr	199 Cr	125 Cr	153 Cr	₹7.76
2022-12-31	1509 Cr	1341 Cr	235 Cr	168 Cr	122 Cr	₹6.20

शेअरहोल्डिंग नमुना

सध्याचे — 2026-03-31

प्रवर्तक69.7%

FII4.3%

DII16.2%

सार्वजनिक30.3%

प्रवर्तक होल्डिंग ट्रेंड

कॉर्पोरेट कार्यवाही

एक्स-तारीख	प्रकार	उद्देश
2025-07-29	Dividend	Dividend - Rs 11 Per Share
2024-07-15	Dividend	Dividend - Rs 11 Per Share
2023-07-28	Dividend	Dividend - Rs 8 Per Share
2022-08-17	Dividend	Interim Dividend - Rs 10 Per Share
2021-07-19	Dividend	Annual General Meeting/Dividend - Rs 14 Per Share
2020-03-16	Dividend	Interim Dividend - Rs 7 Per Share Special Dividend - Rs 3 Per Share
2019-07-18	Dividend	Annual General Meeting/Dividend Rs 5.50/-
2018-07-18	Dividend	Annual General Meeting/Dividend- Rs 4 Per Share (Purpose Revised)
2017-07-11	Dividend	Annual General Meeting/Dividend -Rs 4/- Per Share
2016-07-20	Dividend	Annual General Meeting/Dividend - Rs 4/- Per Share
2015-07-22	Dividend	Annual General Meeting/ Dividend - Rs 3.50/- Per Share
2014-07-17	Dividend	Annual General Meeting / Dividend - Rs 3/- Per Share
2013-07-29	Dividend	Annual General Meeting And Dividend Rs.2.50 Per Share
2012-07-31	Dividend	Annual General Meeting / Dividend Rs 1.40 Per Share

उत्पन्न विवरण

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

4 Nov 2025NSE17K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

5 Aug 2025NSE15K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

6 May 2025NSE17K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

3 Feb 2025NSE17K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

7 Nov 2023NSE16K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

4 Aug 2023NSE12K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

5 May 2023NSE14K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Revision in timings of Post Results ...

26 Apr 2023NSE3K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...

17 Nov 2022NSE32K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional I...

9 Nov 2022NSE3K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...

10 Aug 2022NSE33K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Revision in timings of Post Results ...

2 Aug 2022NSE3K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...

9 May 2022NSE45K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor ...

9 Jan 2019NSE2K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 21...

21 Jan 2016NSE

Read →

Alembic Pharmaceuticals Limited has informed the Exchange that the Company will hold Post Results Co...

19 Jan 2016NSE

Read →

किंमत इतिहास

तारीख	उघडणे	उच्चांक	नीचांक	बंद	व्हॉल्यूम
2026-05-06	७७३.९५	७९३.२०	७६४.७५	७८५.५०	४.१४L
2026-05-05	७६७.००	७७५.००	७६२.९०	७६९.३०	२.४२L
2026-05-04	७५९.९५	७७०.९५	७५५.००	७६५.७५	३.३८L
2026-04-30	७६०.००	७६२.००	७५१.३५	७५५.००	२७,३१४
2026-04-29	७५९.९५	७६९.००	७५३.६०	७६१.१०	५२,४९८
2026-04-28	७६२.५५	७६७.७०	७५३.१५	७५९.४०	३४,९१५
2026-04-27	७८४.८५	७९५.९५	७६०.१०	७६४.६०	१.६७L
2026-04-24	७८१.२५	७८१.२५	७५०.००	७५१.०५	४०,७२४
2026-04-23	७६४.००	७८४.६०	७६१.७५	७६८.७५	६७,५९८
2026-04-22	७६०.८५	७७३.१५	७५८.२५	७६४.६०	३०,२९०
2026-04-21	७५७.५०	७६७.८०	७५०.२०	७६४.३०	६२,९१७
2026-04-20	७८४.८५	७८५.००	७५५.००	७५७.५०	७०,७५७
2026-04-17	७५३.९५	७९७.००	७५१.३५	७८४.७५	२.३८L
2026-04-16	७४६.००	७५३.६५	७३३.२५	७४८.३०	८५,८६०
2026-04-15	७२८.९५	७४१.५०	७२०.१०	७३४.८०	८२,६६०
2026-04-13	७१५.००	७२८.२०	७०४.५०	७१७.५०	४४,८६५
2026-04-10	७२०.२५	७३६.१५	७२०.२५	७२४.२०	३५,५८३
2026-04-09	७२५.९५	७२९.६५	७१५.८५	७२०.१५	४१,५२४
2026-04-08	७१६.००	७४८.००	७००.००	७२६.२५	१.५८L
2026-04-07	६५५.५५	६९५.००	६५२.१५	६९०.१०	१.३५L
2026-04-02	६६६.५०	६७३.५५	६५०.००	६५६.२०	६०,९२२
2026-04-01	६६८.९५	६८१.४५	६६५.२५	६७७.०५	५८,१६२
2026-03-27	६९४.००	६९४.१५	६६६.००	६७३.५५	७.१०L
2026-03-25	६७५.००	६९९.००	६६७.२०	६९४.१५	२.७१L
2026-03-24	६६२.००	६७८.५५	६३८.१५	६७३.२०	१.७४L
2026-03-20	६५६.९५	६८६.९५	६५६.९५	६७७.३०	७०,३८६
2026-03-19	६७०.००	६७१.३५	६५२.००	६५५.४५	४७,९३०
2026-03-18	६७२.९०	६८४.००	६६९.४०	६७६.३०	४७,९१४
2026-03-17	६७५.७५	६८२.४५	६६५.१०	६७०.००	३५,०५३
2026-03-16	६७८.००	६८६.९०	६६७.०५	६७५.३०	५२,३१५

वारंवार विचारले जाणारे प्रश्न

बद्दल

Alembic Pharmaceuticals Limited, भारतातील फार्मास्युटिकल क्षेत्रातील एक प्रमुख खेळाडू, प्रामुख्याने जेनेरिक आणि विशेष फार्मास्युटिकल उत्पादनांच्या विकासावर, उत्पादनावर आणि विपणनावर लक्ष केंद्रित करते. एटोरवास्टॅटिन कॅल्शियम आणि मेटफॉर्मिन हायड्रोक्लोराइड सारख्या प्रमुख फॉर्म्युलेशनसह स्वस्त औषधांच्या विस्तृत श्रेणीसाठी ओळखल्या जाणाऱ्या, कंपनीने 1950 मध्ये स्थापन झाल्यापासून भारतीय जेनेरिक उद्योगात एक महत्त्वपूर्ण योगदानकर्ता म्हणून स्वतःची स्थापना केली आहे.